The FDA assessed the protection and performance of atidarsagene autotemcel based on info from 37 little ones who been given atidarsagene autotemcel in two one-arm, open up-label scientific trials As well as in an expanded entry program.[7] Kids who gained cure with atidarsagene autotemcel were being compared to untreated little ones (natural histor